
SP Doxime XP 1000mg/125mg Injection
Marketer
Medicross Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview SP Doxime XP 1000mg/125mg Injection
Combiflox 1000mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial for complete eradication of the infection. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions warrant immediate medical attention. Allergic responses (e.g., rash, pruritus, edema, dyspnea) necessitate prompt medical help. Inform your physician of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness necessitates abstention from driving. Adequate rest, nutrition, and hydration support recovery. Your doctor may order tests to monitor therapeutic response.
Uses of SP Doxime XP 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of SP Doxime XP 1000mg/125mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of SP Doxime XP 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use SP Doxime XP 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How SP Doxime XP 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam 1000mg/125mg (SP Doxime XP Injection) combines a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside SP Doxime XP 1000mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of SP Doxime XP 1000mg/125mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering SP Doxime XP 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of SP Doxime XP 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of SP Doxime XP 1000mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering SP Doxime XP 1000mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration of SP Doxime XP 1000mg/125mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take SP Doxime XP 1000mg/125mg Injection :
Omitting a scheduled dose of SP Doxime XP 1000mg/125mg Injection requires contacting your physician.
Facts to Know About SP Doxime XP 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
